Bio Green Med Solution, Inc. BGMS
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
-178.61
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $0 | -$3.0M | — | — | $6.8M |
| 2024 | $43,000 | -$11.2M | — | — | -$2.2M |
| 2023 | $420,000 | -$22.6M | — | -$16.1M | $607,000 |
| 2022 | $0 | -$21.2M | — | -$20.8M | $15.9M |
| 2021 | $0 | -$18.9M | — | -$18.6M | $37.7M |
| 2020 | $0 | -$8.4M | — | -$8.0M | $33.3M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Kiu Cu Seng | Chief Financial Officer | 2025-11-12 | Grant | 200,000 | $1.40 |
| Doris Wong Sing Ee | Chief Executive Officer | 2025-11-12 | Grant | 300,178 | $1.40 |
| Yap Kim Choy | 10% owner | 2025-11-05 | Sell | 28,540 | $1.70 |
| Yap Kim Choy | 10% owner | 2025-11-05 | J | 467,535 | — |
| Kua Khai Loon | 10% owner | 2025-11-05 | J | 467,535 | — |
| Ong Yee Lung | 10% owner | 2025-11-05 | J | 467,535 | — |
| Yap Kim Choy | 10% owner | 2025-10-30 | Sell | 112,260 | $1.81 |
| Kua Khai Loon | 10% owner | 2025-10-30 | Sell | 242,477 | $1.80 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -178.61 (distress)
- Working capital / assets 0.602
- Retained earnings / assets -55.518
- EBIT / assets -1.03
- Equity / liabilities 5.095
Source: SEC EDGAR filings · CIK 0001130166 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.